|
WO2021076485A1
|
|
Methods and compositions for treating iron disorders
|
|
WO2020102244A1
|
|
Methods of treating cancer using tubulin binding agents
|
|
AU2019320830A1
|
|
Method and composition for stimulating immune response
|
|
AU2019278886A1
|
|
Composition and method of treating cancer associated with EGFR mutation
|
|
KR20200116477A
|
|
Compositions and methods for reducing chemotherapy-induced neutropenia through administration of plinabulin and G-CSF agents
|
|
CN112135614A
|
|
Compositions and methods for reducing thrombocytopenia by administering plinabulin
|
|
JP2018199726A
|
|
Cancer treatment with combination of plinabulin and taxane
|
|
SG11201908420WA
|
|
Compositions of plinabulin and use thereof
|
|
EP3576733A1
|
|
Method of reducing neutropenia
|
|
EP3565812A1
|
|
Tubulin binding compounds and therapeutic use thereof
|
|
KR20190015361A
|
|
Compositions and methods for reducing neutropenia
|
|
WO2017139231A1
|
|
Compositions containing tucaresol or its analogs
|
|
CN108026075A
|
|
Pune's cloth woods composition
|
|
WO2016144635A1
|
|
Method of treating cancer associated with a ras mutation
|
|
US2018042921A1
|
|
Method of treating a brain tumor
|
|
EP3256130A1
|
|
Use of plinabulin in combination with immune checkpoint inhibitors
|
